Norman L. Sussman
2022
In 2022, Norman L. Sussman earned a total compensation of $849.7K as Chief Medical Officer at DURECT, a 17% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $131,873 |
---|---|
Option Awards | $261,736 |
Salary | $413,332 |
Other | $42,740 |
Total | $849,681 |
Sussman received $413.3K in salary, accounting for 49% of the total pay in 2022.
Sussman also received $131.9K in non-equity incentive plan, $261.7K in option awards and $42.7K in other compensation.
Rankings
In 2022, Norman L. Sussman's compensation ranked 3,374th out of 5,760 executives tracked by ExecPay. In other words, Sussman earned more than 41.4% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 3,374 out of 5,760 | 41st |
Division Manufacturing | 1,906 out of 3,136 | 39th |
Major group Chemicals And Allied Products | 910 out of 1,422 | 36th |
Industry group Drugs | 852 out of 1,323 | 36th |
Industry Pharmaceutical Preparations | 620 out of 969 | 36th |
Source: SEC filing on April 27, 2023.
Sussman's colleagues
We found two more compensation records of executives who worked with Norman L. Sussman at DURECT in 2022.